Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-03-03 02:15 | 2021-03-01 | XOM | EXXON MOBIL CORP | Angelakis Michael J | Director | Petroleum Refining | BUY | $57.16 | 25,000 | $1,429,120 | 33,000 | +312.5% |
| 2021-03-03 00:40 | 2021-02-26 | AGR | N/A | ARRIOLA DENNIS V | Director, Officer - see below | Other | BUY | $46.53 | 25,000 | $1,163,250 | 25,000 | +100.0% |
| 2021-03-03 04:18 | 2021-02-26 | IRWD | IRONWOOD PHARMACEUTICALS INC | DENNER ALEXANDER J | Director | Pharmaceutical Preparations | BUY | $9.44 | 1,350,000 | $12,737,925 | 15,390,000 | +9.6% |
| 2021-03-03 00:30 | 2021-02-26 | STSA | N/A | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | Other | BUY | $5.68 | 1,232,394 | $6,999,998 | 5,155,854 | +31.4% |
| 2021-03-03 03:54 | 2021-02-26 | TREE | LendingTree, Inc. | THOMPSON G KENNEDY | Director | Loan Brokers | BUY | $275.04 | 5,000 | $1,375,200 | 10,000 | +100.0% |
| 2021-03-03 02:23 | 2021-02-26 | CCI | CROWN CASTLE INC. | MARTIN J LANDIS | Director | Real Estate Investment Trusts | BUY | $158.10 | 7,765 | $1,227,643 | 450 | +100.0% |
| 2021-03-03 00:30 | 2021-02-26 | DHR | DANAHER CORP /DE/ | RALES MITCHELL P | Director, Officer - Chairman of Exec. Committee | Industrial Instruments For Measurement, Display, and Control | BUY | $221.55 | 6,600 | $1,462,260 | 3,156 | +100.0% |
| 2021-03-02 00:36 | 2021-02-09 | FWAA | SmartRent, Inc. | Mykhaylovskyy Andriy | Director, Officer - Chief Financial Officer | Services-Computer Integrated Systems Design | BUY | $10.00 | 1,047,500 | $10,475,000 | 1,047,500 | +100.0% |
| 2021-03-02 00:35 | 2021-02-09 | FWAA | SmartRent, Inc. | Wallace Brendan | Director, Officer - Chairman of the Board and CEO | Services-Computer Integrated Systems Design | BUY | $10.00 | 1,047,500 | $10,475,000 | 1,047,500 | +100.0% |
| 2021-03-02 00:33 | 2021-02-09 | FWAA | SmartRent, Inc. | Fifth Wall Acquisition Sponsor, LLC | 10% owner | Services-Computer Integrated Systems Design | BUY | $10.00 | 1,047,500 | $10,475,000 | 1,047,500 | +100.0% |
| 2021-03-02 01:57 | 2021-02-26 | SAII | N/A | Mithaq Capital SPC | 10% owner | Other | BUY | $11.34 | 130,860 | $1,483,952 | 4,264,550 | +3.2% |
| 2021-03-01 21:26 | 2021-02-26 | N-A | N/A | Manufacturers Life Insurance Co (Bermuda Branch) | 10% owner | Other | BUY | $21.33 | 200,695 | $4,280,001 | 7,314,490 | +2.8% |
| 2021-02-27 01:17 | 2021-02-25 | SAII | N/A | Mithaq Capital SPC | 10% owner | Other | BUY | $11.32 | 1,193,292 | $13,508,065 | 4,220,930 | +39.4% |
| 2021-02-27 02:00 | 2021-02-12 | LGVN | Longeveron Inc. | Soffer Donald M | Director | Pharmaceutical Preparations | BUY | $10.00 | 100,000 | $1,000,000 | 153,514 | +186.9% |
| 2021-02-26 23:33 | 2021-02-24 | IBAL | N/A | Avis Industrial Corp | 10% owner | Other | BUY | $1.20 | 2,633,896 | $3,160,675 | 4,205,158 | +167.6% |
| 2021-02-27 03:46 | 2021-02-25 | RPRX | Royalty Pharma plc | Fernandez Henry A | Director | Pharmaceutical Preparations | BUY | $46.83 | 25,700 | $1,203,480 | 25,700 | +100.0% |
| 2021-02-25 19:54 | 2021-02-24 | SAII | N/A | Mithaq Capital SPC | 10% owner | Other | BUY | $11.35 | 183,813 | $2,086,278 | 3,823,166 | +5.1% |
| 2021-02-26 02:00 | 2021-02-23 | PRTA | PROTHENA CORP PUBLIC LTD CO | EcoR1 Capital, LLC | 10% owner | Pharmaceutical Preparations | BUY | $21.24 | 55,200 | $1,172,387 | 10,159,280 | +0.5% |
| 2021-02-25 22:46 | 2021-02-23 | MTEM | N/A | BIOTECH TARGET N V | 10% owner | Other | BUY | $11.33 | 310,004 | $3,513,864 | 8,036,105 | +4.0% |
| 2021-02-26 00:00 | 2021-02-23 | CFVI | Rumble Inc. | CFAC Holdings VI, LLC | 10% owner | Services-Computer Programming, Data Processing, Etc. | BUY | $10.00 | 700,000 | $7,000,000 | 700,000 | +100.0% |
| 2021-02-25 01:43 | 2021-02-23 | SAII | N/A | Mithaq Capital SPC | 10% owner | Other | BUY | $11.03 | 1,561,923 | $17,228,011 | 3,761,895 | +71.0% |
| 2021-02-24 19:21 | 2021-02-22 | FSRXU | N/A | Einbinder Lee | Director, Officer, 10% owner - Chief Executive Officer | Other | BUY | $10.00 | 800,000 | $8,000,000 | 800,000 | +100.0% |
| 2021-02-24 19:26 | 2021-02-16 | AUUD | AUDDIA INC. | Thramann Jeffrey John | Director, Officer, 10% owner - Executive Chairman | Services-Computer Processing & Data Preparation | BUY | $4.13 | 969,697 | $4,000,000 | 1,682,349 | +136.1% |
| 2021-02-25 00:06 | 2021-02-16 | AUUD | AUDDIA INC. | Thramann Jeffrey John | Director, Officer, 10% owner - Executive Chairman | Services-Computer Processing & Data Preparation | BUY | $4.13 | 969,000 | $3,997,125 | 1,681,652 | +136.0% |
| 2021-02-25 01:50 | 2021-02-22 | ADC | Agree Realty Corporation | RAKOLTA JOHN JR | Director | Real Estate Investment Trusts | BUY | $63.63 | 19,525 | $1,242,411 | 235,613 | +9.0% |
| 2021-02-24 01:21 | 2021-02-22 | SAII | N/A | Mithaq Capital SPC | 10% owner | Other | BUY | $11.49 | 658,485 | $7,565,993 | 3,241,254 | +25.5% |
| 2021-02-23 16:11 | 2021-02-19 | CAR | AVIS BUDGET GROUP, INC. | Choi Brian J | Officer - EVP & Chief Financial Officer | Services-Auto Rental & Leasing (No Drivers) | BUY | $45.88 | 23,735 | $1,089,033 | 23,735 | +100.0% |
| 2021-02-24 00:54 | 2021-02-23 | INCY | INCYTE CORP | Hoppenot Herve | Director, Officer, Other - Chairman / CEO | Services-Commercial Physical & Biological Research | BUY | $77.37 | 12,925 | $1,000,007 | 284,231 | +4.8% |
| 2021-02-24 01:34 | 2021-02-19 | FSII | N/A | FS Development Holdings II, LLC | 10% owner | Other | BUY | $10.00 | 602,500 | $6,025,000 | 602,500 | +100.0% |
| 2021-02-24 02:32 | 2021-02-22 | PACE | Nerdy Inc. | LIGHT STREET CAPITAL MANAGEMENT, LLC | 10% owner | Services-Educational Services | BUY | $11.11 | 145,000 | $1,611,661 | 300,000 | +93.5% |
| 2021-02-23 23:57 | 2021-02-18 | PRTA | PROTHENA CORP PUBLIC LTD CO | EcoR1 Capital, LLC | 10% owner | Pharmaceutical Preparations | BUY | $23.65 | 44,100 | $1,043,075 | 10,104,080 | +0.4% |
| 2021-02-24 02:47 | 2021-02-19 | ZTS | Zoetis Inc. | SCULLY ROBERT W | Director | Pharmaceutical Preparations | BUY | $164.68 | 7,590 | $1,249,931 | 7,590 | +100.0% |
| 2021-02-23 00:35 | 2021-02-22 | USLM | UNITED STATES LIME & MINERALS INC | INBERDON ENTERPRISES LTD | 10% owner | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | BUY | $139.80 | 10,729 | $1,499,914 | 3,489,119 | +0.3% |
| 2021-02-22 15:37 | 2021-02-19 | OPK | OPKO HEALTH, INC. | FROST PHILLIP MD ET AL | Director, Officer, 10% owner - CEO & Chairman | Pharmaceutical Preparations | BUY | $4.77 | 500,000 | $2,383,450 | 191,871,694 | +0.3% |
| 2021-02-23 01:27 | 2021-02-19 | SONO | Sonos Inc | Volpi Michelangelo | Director | Household Audio & Video Equipment | BUY | $37.35 | 53,666 | $2,004,345 | 53,774 | +49,690.7% |
| 2021-02-23 01:12 | 2021-02-18 | AAT | American Assets Trust, Inc. | RADY ERNEST S | Director, Officer, 10% owner - Chairman, CEO & President | Real Estate Investment Trusts | BUY | $29.50 | 117,998 | $3,480,457 | 1,791,447 | +7.1% |
| 2021-02-23 04:13 | 2021-02-19 | FSP | FRANKLIN STREET PROPERTIES CORP /MA/ | MCGILLICUDDY DENNIS J | Director | Real Estate Investment Trusts | BUY | $4.22 | 300,552 | $1,267,067 | 3,023,408 | +11.0% |
| 2021-02-19 23:47 | 2021-02-19 | PRCIX | N/A | DURON S COLEMAN TRUST | Officer - Beneficiary | Other | BUY | $9.82 | 25,873,891 | $254,081,610 | 25,873,891 | +100.0% |
| 2021-02-19 23:39 | 2021-02-19 | FDEQX | N/A | DURON S COLEMAN TRUST | Officer - Beneficiary | Other | BUY | $50.51 | 1,288,872 | $65,100,925 | 1,288,872 | +100.0% |
| 2021-02-20 01:40 | 2020-10-01 | IMPX | N/A | Garcia John L | Director, Officer - Co-Chief Executive Officer | Other | BUY | $10.00 | 2,500,000 | $25,000,000 | 2,500,000 | +100.0% |
| 2021-02-20 02:59 | 2021-02-17 | DBTX | N/A | Foy Matthew | Director, 10% owner | Other | BUY | $18.00 | 150,000 | $2,700,000 | 1,183,663 | +14.5% |
| 2021-02-20 02:13 | 2021-02-17 | TLIS | N/A | Posard Matthew L. | Director | Other | BUY | $16.00 | 62,500 | $1,000,000 | 62,500 | +100.0% |
| 2021-02-20 00:25 | 2021-02-17 | NEXI | NexImmune Inc. | Verstandig Grant | Director | Pharmaceutical Preparations | BUY | $17.00 | 175,000 | $2,975,000 | 714,895 | +32.4% |
| 2021-02-20 02:56 | 2021-02-17 | DBTX | N/A | Casdin Partners Master Fund, L.P. | 10% owner | Other | BUY | $18.00 | 575,000 | $10,350,000 | 1,121,421 | +105.2% |
| 2021-02-20 00:47 | 2021-02-17 | CRVS | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director, 10% owner | Pharmaceutical Preparations | BUY | $3.50 | 1,285,714 | $4,499,999 | 8,053,298 | +19.0% |
| 2021-02-20 02:50 | 2021-02-17 | DBTX | N/A | Thompson Peter A. | Director, 10% owner | Other | BUY | $18.00 | 1,666,666 | $29,999,988 | 883,418 | +100.0% |
| 2021-02-20 02:18 | 2021-02-17 | TLIS | N/A | Scott Randal W. | Director | Other | BUY | $16.00 | 312,500 | $5,000,000 | 312,500 | +100.0% |
| 2021-02-20 00:20 | 2021-02-17 | NEXI | NexImmune Inc. | BARER SOL J | Director | Pharmaceutical Preparations | BUY | $17.00 | 60,000 | $1,020,000 | 1,538,013 | +4.1% |
| 2021-02-20 01:28 | 2021-02-18 | MTEM | N/A | BIOTECH TARGET N V | 10% owner | Other | BUY | $12.65 | 1,185,770 | $14,999,991 | 7,726,101 | +18.1% |
| 2021-02-20 00:17 | 2021-02-17 | ATEX | Anterix Inc. | Owl Creek Asset Management, L.P. | 10% owner | Telephone Communications (No Radiotelephone) | BUY | $42.93 | 151,117 | $6,486,909 | 5,402,132 | +2.9% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.